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Abstract Quantum dots exhibit unique optical properties
for bioimaging purposes. We have previously developed
quantum dots with a paramagnetic and functionalized
coating and have shown their potential for molecular
imaging purposes. In the current mini-review we summa-
rize the synthesis procedure, the in vitro testing and,
importantly, the in vivo application for multimodal
molecular imaging of tumor angiogenesis.
Keywords Quantum dots  Molecular imaging 
Angiogenesis  Multimodal imaging  Magnetic resonance
imaging  Fluorescence imaging  Intravital microscopy
Introduction
Quantum dots (QDs), semiconductor nanocrystals, have
exceptional optical properties, which make them ideally
suited for a number of applications in biomedical imaging,
with several important advantages over fluorescent dye-
molecules [1, 2]. The absorption spectrum of a QD is very
broad, while the emission spectrum is narrow. The exact
optical properties of QDs can be tuned by a precise control
of composition and size, allowing the synthesis of QDs
with emission wavelengths spanning from the near UV to
near infrared (NIR), making QDs particularly suitable for
multiplexed imaging [3]. Importantly for biological appli-
cations, the surface of QDs can be easily modified to render
them water-soluble and biocompatible as well as to allow
the introduction of additional functionalities and to make
them target-specific. Dubertret and colleagues were the first
to apply quantum dots to a living organism (Xenopus
embryos) for in vivo imaging purposes [4]. To that end
they encapsulated the QD nanocrystals in phospholipid
micelles. Previously, we modified their procedure to create
QD-based nanoparticles that can be detected by optical
techniques as well as magnetic resonance imaging (MRI).
Using this approach we have created QD based nanopar-
ticles that specifically bind activated endothelial cells to
image ongoing angiogenesis [5, 6].
Synthesis of paramagnetic QD-micelles
The original procedure involves mixing of QDs that are
coated with hydrophobic capping molecules with an excess
of PEGylated phospholipids (PEG-lipids) and Gd-DTPA
labeled lipids (Gd-DTPA-DSA) in chloroform. Upon
evaporation of the solvent, a mixed film containing the
lipids and QDs is formed. Hydrating and heating this film
results in the formation of paramagnetic micelles that
contain a QD in their core. This procedure results in the
formation of a relatively large fraction of aggregated QDs
coated by the PEG-lipids. To increase the yield of para-
magnetic micelles with a single QD core we modified the
procedure as illustrated in Fig. 1. The new method involves
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slow infusion of the chloroform QD/lipid mixture into hot
water, which results in the formation of chloroform-in-
water emulsions that swiftly form micelles as chloroform
evaporates. The resulting mix of QD core micelles and
empty micelles is separated by centrifugation methods. The
relaxivity of purified paramagnetic QD-micelles is
approximately 2,000 mM-1s-1 (per mM nanoparticles) at
a clinically relevant field strength of 1.41 T, which makes
them attractive for molecular MRI purposes [7, 8].
By the inclusion of maleimide functionalized PEG-lip-
ids (Mal-PEG-lipid), the paramagnetic QD-micelles can be
functionalized via a sulfhydryl-maleimide coupling
method. Using this strategy, we have shown the conjuga-
tion of avb3-integrin specific cyclic RGD peptides [5, 9]
and phosphatidylserine specific Annexin A5 proteins [6] to
the paramagnetic QD-micelles, but also the conjugation of
E-selectin specific antibodies to paramagnetic liposomes
[10].
In vitro targeting and imaging
To assess the biological specificity of the RGD and Annexin
A5 conjugated paramagnetic QD-micelles (abbreviated as
RGD-pQD and A5-pQD, respectively) human umbilical
vein endothelial cells (HUVEC) and Jurkat cells were used
for in vitro testing, respectively. Growth factor activated and
proliferating HUVEC overexpress the avb3-integrin, while
Jurkat cells exposed to anti-Fas become apoptotic and
expose the negatively charged phospholipid phosphatidyl-
serine (PS) at the outer layer of the cell membrane. Both
markers are known to be expressed in angiogenic blood
vessels. In Fig. 2a a T1-weighted MR image of loosely
packed cells, 1.5 million per pellet, is shown. The pellet of
cells incubated with the targeted RGD-pQDs appeared much
brighter than those that were incubated with non-targeted
pQDs or that were not incubated with contrast agent. A
fluorescence microscopy image of HUVEC that had been
incubated with green emitting RGD-pQDs is depicted in
Fig. 2a (right) and showed the nanoparticles to be internal-
ized, at a perinuclear location (inset). In Fig. 2b Jurkat cell
pellets are shown that were illuminated with 254 nm UV
light. The green emitting cell pellet originating from the A5-
pQDs incubated PS expressing cells can be clearly distin-
guished from the control cell pellets.
Multimodality molecular imaging of tumor
angiogenesis
To evaluate the in vivo potential of RGD-pQDs we
designed a study where different groups of tumor bearing
mice were imaged in vivo with fluorescence intravital
microscopy (IVM), MRI, or whole body fluorescence
imaging (Fig. 3, left) [9]. IVM was used to monitor
nanoparticle binding to the tumor vasculature in real-time.
We observed labeling of tumor blood vessels within
5–10 min after the administration of RGD-pQDS. A typi-
cal fluorescence image is depicted in Fig. 3. Labeling of
endothelial cells in the tumor vasculature by RGD-pQDs
was found as far as 1 cm from the tumor periphery,
indicative for a widespread activation of the blood vessels
in close proximity of cancerous tissue. No endothelial cell
labeling of blood vessels in the hind limb of the animals
and of blood vessels in the ears of the animals was
observed.
MRI was performed on a different group of animals
that were intravenously injected with RGD-pQD. A high
resolution T1-weighted image, acquired 45 min after
contrast agent injection, revealed angiogenic activity to be
mainly found at the rim of the tumor, which corresponds
with the regions of the tumor with highest angiogenic
activity.
Lastly, whole body fluorescence imaging was employed
to visualize angiogenesis in nude mice that grew a tumor in
their kidney (Fig. 3, bottom). This technique has a higher
sensitivity and temporal resolution than MRI and thus
allows faster screening of nanoparticle targeting, albeit
Fig. 1 Schematic
representation of the synthesis
of QDs with a paramagnetic
micellar coating. QDs and lipids
in chloroform are slowly
infused in hot water that, via
chloroform-in-water emulsions,
swiftly form micelles when
chloroform evaporates, some of
which have a QD core
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with less spatial information than is the case for MRI.
Altogether, IVM, MRI and fluorescence imaging are
complementary imaging modalities that, when combined
with our nanoparticle, can provide information about
angiogenesis at the microscopic level of superficial blood
vessels (IVM), at the whole mouse level with high sensi-
tivity and temporal resolution (fluorescence imaging), as
well as three dimensional information of the inside of the
mouse and tumor (MRI).
Discussion and conclusion
QDs represent an excellent tool for multimodal molecular
imaging of angiogenesis. It was recently demonstrated that
these nanocrystals can be used to image the tumor micro-
environment and that differently sized quantum dots can be
used to assess the permeability of the tumor microvascu-
lature [11]. Subsequent to the lipid-based QD platform we
introduced, Oostendorp and colleagues demonstrated the
functionalization of QDs with paramagnetic dendritic
wedges and CD13 specific cNGR peptides to allow MR
molecular imaging of tumor angiogenesis [12] as well as
angiogenesis after myocardial infarction [13]. The fluo-
rescence properties of the QDs were exploited to validate
their findings with ex vivo two-photon laser scanning
microscopy, which showed the QDs to be co-localized with
endothelial cells. In addition to labeling QDs for MRI,
studies have shown the value of the combination with
positron emission tomography (PET) imaging. Cai and
colleagues used radiolabeled and RGD peptide function-
alized QDs to accomplish molecular imaging of tumor
angiogenesis [14], while Chen et al. demonstrated the same
using radiolabeled QDs that were functionalized with
vascular endothelial growth factor [15]. Since our nano-
particle platform contains DTPA functionalized lipids the
inclusion of a radiolabel should be relatively straightfor-
ward and may be introduced as a third label to additionally
allow PET imaging. Interestingly, the flexibility of the QD-
micelle platform also allows the possibility to include
therapeutics [16] or additional targeting moieties to
enhance the specificity of targeting, as was recently dem-
onstrated by Kluza et al. for a liposomal nanoparticle [17].
In conclusion this mini-review presented the develop-
ment of paramagnetic QD-micelles for MR and optical
based molecular imaging. The ease of preparation and
flexibility, as well as their use as a scaffold that is repre-
sentative of other nanocrystals make them fruitful tools for
biomedical imaging purposes. Their application may be
Fig. 2 In vitro targeting and imaging with QD-micelles. a, left
T1-weighted MRI image of cells that were incubated with RGD-
pQDs, pQDS, or without contrast agent. a, right Fluorescence
microscopy of HUVEC incubated with RGD-pQDs. b Pellets of
Jurkatt cells of different incubations illuminated with 254 nm UV
light. From left to right: [1] Control cells. [2] Apoptotic cells treated
with EDTA to remove Ca2?, which prevents binding [3] vital cells,
and [4] apoptotic cells, all incubated with Annexin A5 functionalized
QD-micelles revealed the highest uptake in situation [4]
Fig. 3 Multimodal molecular imaging of tumor angiogenesis using
QD-micelles. (Top) Intravital microscopy of microvessels in tumor-
bearing mice after intravenous injection of avb3-specific and
paramagnetic QD-micelles. (Middle) T1-weighted MR images 45 min
after the injection of the nanoparticles in a mouse bearing a
subcutaneous tumor. The colored pixels in the tumor highlight the
location of the MR-visible QD-micelles, predominantly in the rim of
the tumor. (Bottom) Fluorescence image of a mouse, inoculated with a
tumor in the kidney, following intravenous administration
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extended to other imaging modalities, to other disease
processes than angiogenesis, as well as for drug targeting
purposes.
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